Functional significance of the perforin/granzyme cell death pathway

Perforin/granzyme-induced apoptosis is the main pathway used by cytotoxic lymphocytes to eliminate virus-infected or transformed cells. Studies in gene-disrupted mice indicate that perforin is vital for cytotoxic effector function; it has an indispensable, but undefined, role in granzyme-mediated apoptosis. Despite its vital importance, the molecular and cellular functions of perforin and the basis of perforin and granzyme synergy remain poorly understood. The purpose of this review is to evaluate critically recent findings on cytotoxic granule-mediated cell death and to assess the functional significance of postulated cell-death pathways in appropriate pathophysiological contexts, including virus infection and susceptibility to experimental or spontaneous tumorigenesis.

[1]  P. Bird Regulation of pro‐apoptotic leucocyte granule serine proteinases by intracellular serpins , 1999, Immunology and cell biology.

[2]  K. Jiang,et al.  A View to a Kill : Signals Triggering Cytotoxicity 1 , 2002 .

[3]  M. V. D. van den Brink,et al.  Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect. , 2001, Blood.

[4]  S. Burakoff,et al.  Cytolytic pathways in haematopoietic stem-cell transplantation , 2002, Nature Reviews Immunology.

[5]  R. Zinkernagel,et al.  Decreased tumor surveillance in perforin-deficient mice , 1996, The Journal of experimental medicine.

[6]  R. Ahmed,et al.  Distinct CD8 T Cell Functions Mediate Susceptibility to Histoplasmosis During Chronic Viral Infection1 , 2001, The Journal of Immunology.

[7]  R. Zinkernagel,et al.  Perforin‐independent regulation of dendritic cell homeostasis by CD8+ T cells in vivo: implications for adaptive immunotherapy , 2001, European journal of immunology.

[8]  S. Landolfo,et al.  Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection , 2000, European journal of immunology.

[9]  N. Jenkins,et al.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand , 1994, Cell.

[10]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[11]  D. Marmer,et al.  Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. , 2002, Blood.

[12]  D. Newmeyer,et al.  A Distinct Pathway of Cell-Mediated Apoptosis Initiated by Granulysin1 , 2001, The Journal of Immunology.

[13]  S. Miller,et al.  Enhanced susceptibility to Theiler's virus-induced demyelinating disease in perforin-deficient mice , 2001, Journal of Neuroimmunology.

[14]  J. Lieberman,et al.  Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation. , 1999, Immunity.

[15]  Marion E. Schneider,et al.  Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. , 2001, American journal of human genetics.

[16]  R. Gottlieb,et al.  New Paradigm for Lymphocyte Granule-mediated Cytotoxicity , 1996, The Journal of Biological Chemistry.

[17]  R. Seder,et al.  Perforin Is Required for Primary Immunity to Histoplasma capsulatum , 2001, The Journal of Immunology.

[18]  B. Graham,et al.  IL-4 Diminishes Perforin-Mediated and Increases Fas Ligand-Mediated Cytotoxicity In Vivo1 , 2000, The Journal of Immunology.

[19]  A. Yoshimi,et al.  Epstein–Barr virus‐specific T‐cell cytotoxicity is mediated through the perforin pathway in patients with lymphoproliferative disorders after allogeneic bone marrow transplantation , 2002, British journal of haematology.

[20]  P. Galle,et al.  Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implications. , 1998, Molecular medicine today.

[21]  J. Trapani,et al.  Localization of Granzyme B in the Nucleus , 1996, The Journal of Biological Chemistry.

[22]  A. Hayday,et al.  Regulation of Cutaneous Malignancy by γδ T Cells , 2001, Science.

[23]  R. Zinkernagel,et al.  Reduced Incidence and Delayed Onset of Diabetes in Perforin-deficient Nonobese Diabetic Mice , 1997, The Journal of experimental medicine.

[24]  C. Biron,et al.  NK cells and NKT cells in innate defense against viral infections. , 2001, Current opinion in immunology.

[25]  C. Meijer,et al.  Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system? , 2002, Blood.

[26]  D. Vaux,et al.  Bcl-2 prevents apoptosis induced by perforin and granzyme B, but not that mediated by whole cytotoxic lymphocytes. , 1997, Journal of immunology.

[27]  Hans Hengartner,et al.  Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.

[28]  L. Galle,et al.  Pathogenesis of Herpes Simplex Virus Type 1-Induced Corneal Inflammation in Perforin-Deficient Mice , 2000, Journal of Virology.

[29]  R. Zinkernagel,et al.  Aplastic Anemia Rescued by Exhaustion of Cytokine-secreting CD8+ T Cells in Persistent Infection with Lymphocytic Choriomeningitis Virus , 1998, The Journal of experimental medicine.

[30]  M. Simon,et al.  Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Offringa,et al.  Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Berzofsky,et al.  Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. , 1997, Immunity.

[33]  J. Moslehi,et al.  Perforin protects against autoimmunity in lupus-prone mice. , 1998, Journal of immunology.

[34]  J. Krauss,et al.  T Cell-Mediated Tumor Rejection Displays Diverse Dependence Upon Perforin and IFN-γ Mechanisms That Cannot Be Predicted From In Vitro T Cell Characteristics1 , 2000, The Journal of Immunology.

[35]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[36]  J. Tschopp,et al.  Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease , 1996, The Journal of experimental medicine.

[37]  R. Aebersold,et al.  Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions , 1992, The Journal of experimental medicine.

[38]  Douglas D. Richman,et al.  HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function , 2000, The Journal of experimental medicine.

[39]  D. Moskophidis,et al.  Critical Role for Perforin-, Fas/FasL-, and TNFR1-Mediated Cytotoxic Pathways in Down-Regulation of Antigen-Specific T Cells during Persistent Viral Infection , 2002, Journal of Virology.

[40]  A. Fischer,et al.  Perforin gene defects in familial hemophagocytic lymphohistiocytosis. , 1999, Science.

[41]  J. Trapani,et al.  Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells , 2000, The Journal of experimental medicine.

[42]  T. Utsugi,et al.  Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice. , 1999, The Journal of clinical investigation.

[43]  S. Korsmeyer,et al.  Granzyme B can cause mitochondrial depolarization and cell death in the absence of BID, BAX, and BAK , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R. Ahmed,et al.  A Role for Perforin in Downregulating T-Cell Responses during Chronic Viral Infection , 1999, Journal of Virology.

[45]  K. Ebnet,et al.  Granzyme A is critical for recovery of mice from infection with the natural cytopathic viral pathogen, ectromelia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  T. Ley,et al.  Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[47]  A. Saunders,et al.  A molecular genetic linkage map of mouse chromosome 7. , 1990, Genomics.

[48]  T. Ganz,et al.  An antimicrobial activity of cytolytic T cells mediated by granulysin. , 1998, Science.

[49]  J. Harty,et al.  Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma. , 2000, Science.

[50]  J. Trapani,et al.  The Relative Role of Lymphocyte Granule Exocytosis versus Death Receptor-Mediated Cytotoxicity in Viral Pathophysiology , 1998, Journal of Virology.

[51]  Diego Piccioli,et al.  Contact-dependent Stimulation and Inhibition of Dendritic Cells by Natural Killer Cells , 2002, The Journal of experimental medicine.

[52]  D. Sharma,et al.  Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance. , 2000, Experimental parasitology.

[53]  M. Smyth,et al.  NKT cells: facts, functions and fallacies. , 2000, Immunology today.

[54]  M. Smyth,et al.  Perforin is a major contributor to NK cell control of tumor metastasis. , 1999, Journal of immunology.

[55]  T. Mak,et al.  Homeostatic regulation of CD8+ T cells by perforin , 1999, European journal of immunology.

[56]  Dominik Wodarz,et al.  Direct quantitation of rapid elimination of viral antigen‐positive lymphocytes by antiviral CD8+ T cells in vivo , 2000, European journal of immunology.

[57]  E. Podack,et al.  Perforin/Fas-ligand double deficiency is associated with macrophage expansion and severe pancreatitis. , 1998, Journal of immunology.

[58]  H. Pircher,et al.  Concerted Action of the FasL/Fas and Perforin/Granzyme A and B Pathways Is Mandatory for the Development of Early Viral Hepatitis but Not for Recovery from Viral Infection , 2001, Journal of Virology.

[59]  A. Abbas,et al.  Role of Fas-mediated cell death in the regulation of immune responses. , 1996, Current opinion in immunology.

[60]  Granzyme B Induces Bid-Mediated Cytochrome C Release and Mitochondrial Permeability Transition , 2001, TheScientificWorldJournal.

[61]  R. Schreiber,et al.  IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.

[62]  A. Strasser,et al.  Transgenic overexpression of human Bcl-2 in islet beta cells inhibits apoptosis but does not prevent autoimmune destruction. , 2000, International immunology.

[63]  J. Trapani,et al.  Granzyme B (GraB) Autonomously Crosses the Cell Membrane and Perforin Initiates Apoptosis and GraB Nuclear Localization , 1997, The Journal of experimental medicine.

[64]  E. Podack,et al.  Structure, Function and Expression of Murine and Human Perforin 1 (P1) , 1988, Immunological reviews.

[65]  J. Uitto,et al.  Papillon-Lefèvre syndrome: mutations and polymorphisms in the cathepsin C gene. , 2001, The Journal of investigative dermatology.

[66]  N. Restifo Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape , 2000, Nature Medicine.

[67]  L. Corey,et al.  HSV and Glycoprotein J Inhibit Caspase Activation and Apoptosis Induced by Granzyme B or Fas1 , 2001, The Journal of Immunology.

[68]  R G Miller,et al.  A role for perforin in activation-induced T cell death in vivo: increased expansion of allogeneic perforin-deficient T cells in SCID mice. , 1999, Journal of immunology.

[69]  J. Trapani,et al.  Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. , 2002, Immunity.

[70]  G. Kroemer,et al.  A Role of the Mitochondrial Apoptosis-Inducing Factor in Granulysin-Induced Apoptosis1 , 2001, The Journal of Immunology.

[71]  Mamoru Ito,et al.  Perforin‐dependent NK cell cytotoxicity is sufficient for anti‐metastatic effect of IL‐12 , 1999, European journal of immunology.

[72]  L. Page,et al.  L is for lytic granules: lysosomes that kill. , 1998, Biochimica et biophysica acta.

[73]  J. Christensen,et al.  Compromised virus control and augmented perforin-mediated immunopathology in IFN-gamma-deficient mice infected with lymphocytic choriomeningitis virus. , 1999, Journal of immunology.

[74]  Philippa Marrack,et al.  T cells down-modulate peptide-MHC complexes on APCs in vivo , 2002, Nature Immunology.

[75]  D. Green,et al.  Granzyme B–Mediated Cytochrome C Release Is Regulated by the Bcl-2 Family Members Bid and Bax , 2000, The Journal of experimental medicine.

[76]  R. Moyer,et al.  Poxvirus-encoded serpins do not prevent cytolytic T cell-mediated recovery from primary infections. , 1999, Journal of immunology.

[77]  J. Schatzle,et al.  Perforin‐ and Fas‐dependent mechanisms of natural killer cell‐mediated rejection of incompatible bone marrow cell grafts , 2002, European journal of immunology.

[78]  A. Frey,et al.  CD8+ Tumor-Infiltrating T Cells Are Deficient in Perforin-Mediated Cytolytic Activity Due to Defective Microtubule-Organizing Center Mobilization and Lytic Granule Exocytosis , 2001, The Journal of Immunology.

[79]  R. Aebersold,et al.  A natural killer cell granule protein that induces DNA fragmentation and apoptosis , 1992, The Journal of experimental medicine.

[80]  D. Harlan,et al.  A mouse CD8 T cell-mediated acute autoimmune diabetes independent of the perforin and Fas cytotoxic pathways: possible role of membrane TNF. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[81]  L. Young,et al.  Perforin-mediated myocardial damage in acute myocarditis , 1990, The Lancet.

[82]  Y. Aizawa,et al.  Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation , 1999 .

[83]  J. Trapani,et al.  Perforin-Mediated Cytotoxicity Is Critical for Surveillance of Spontaneous Lymphoma , 2000, The Journal of experimental medicine.

[84]  M. Simon,et al.  Perforin Is Essential for Control of Ectromelia Virus but Not Related Poxviruses in Mice , 1999, Journal of Virology.

[85]  N. Sarvetnick,et al.  Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus. , 1999, Journal of immunology.

[86]  T. Sayers,et al.  Tumor-Specific CTL Kill Murine Renal Cancer Cells Using Both Perforin and Fas Ligand-Mediated Lysis In Vitro, But Cause Tumor Regression In Vivo in the Absence of Perforin1 , 2002, The Journal of Immunology.

[87]  P. Henkart,et al.  Surface Cathepsin B Protects Cytotoxic Lymphocytes from Self-destruction after Degranulation , 2002, Journal of Experimental Medicine.

[88]  A. Kelso,et al.  A Clonal Culture System Demonstrates That IL-4 Induces a Subpopulation of Noncytolytic T Cells with Low CD8, Perforin, and Granzyme Expression1 , 2002, The Journal of Immunology.

[89]  M. Smyth,et al.  Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells , 2001, Nature Medicine.

[90]  R. Zinkernagel,et al.  Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. , 1996, Annual review of immunology.

[91]  R. Bleackley,et al.  Cytotoxic T lymphocytes: all roads lead to death , 2002, Nature Reviews Immunology.

[92]  K. Ebnet,et al.  Granzyme A‐deficient mice retain potent cell‐mediated cytotoxicity. , 1995, The EMBO journal.

[93]  J. Trapani,et al.  Granzyme A and B‐deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti‐tumor capacity , 2001, European journal of immunology.

[94]  Philippa Marrack,et al.  T Cells Compete for Access to Antigen-Bearing Antigen-Presenting Cells , 2000, The Journal of experimental medicine.

[95]  J. Trapani,et al.  Granzymes: exogenous proteinases that induce target cell apoptosis. , 1995, Immunology today.

[96]  M. Smyth,et al.  Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. , 2001, Blood.

[97]  N. Thornberry,et al.  Adenovirus L4-100K assembly protein is a granzyme B substrate that potently inhibits granzyme B-mediated cell death. , 2001, Immunity.

[98]  Timothy J. Ley,et al.  Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells , 1994, Cell.

[99]  T. Ley,et al.  Granzyme A initiates an alternative pathway for granule-mediated apoptosis. , 1999, Immunity.

[100]  G. Griffiths,et al.  Granzymes A and B are targeted to the lytic granules of lymphocytes by the mannose-6-phosphate receptor , 1993, The Journal of cell biology.

[101]  J. Schatzle,et al.  Inhibition of the Death Receptor Pathway by cFLIP Confers Partial Engraftment of MHC Class I-Deficient Stem Cells and Reduces Tumor Clearance in Perforin-Deficient Mice1 , 2001, The Journal of Immunology.

[102]  G. Korbutt,et al.  Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor Is a Death Receptor for Granzyme B during Cytotoxic T Cell–Induced Apoptosis , 2000, Cell.

[103]  K. Elkon,et al.  Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity. , 2000, The Journal of clinical investigation.

[104]  K. Ravichandran,et al.  Phosphatidylinositol 3-kinase-dependent and -independent cytolytic effector functions. , 1999, Journal of immunology.

[105]  J. Trapani,et al.  Efficient Nuclear Targeting of Granzyme B and the Nuclear Consequences of Apoptosis Induced by Granzyme B and Perforin Are Caspase-dependent, but Cell Death Is Caspase-independent* , 1998, The Journal of Biological Chemistry.

[106]  J. Tschopp,et al.  Myelin oligodendrocyte glycoprotein‐induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas‐ and Fas ligand‐deficient lpr and gld mice , 1997, European journal of immunology.

[107]  E. Haddad,et al.  Defective Granule Exocytosis in Rab27a-Deficient Lymphocytes from Ashen Mice , 2001, The Journal of cell biology.

[108]  T. Ley,et al.  Long-range disruption of gene expression by a selectable marker cassette. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[109]  J. Trapani,et al.  Cytosolic Delivery of Granzyme B by Bacterial Toxins: Evidence that Endosomal Disruption, in Addition to Transmembrane Pore Formation, Is an Important Function of Perforin , 1999, Molecular and Cellular Biology.

[110]  M. Smyth,et al.  Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) Contributes to Interferon γ–Dependent Natural Killer Cell Protection from Tumor Metastasis , 2001, The Journal of experimental medicine.

[111]  R. Zinkernagel,et al.  The roles of perforin‐ and Fas‐dependent cytotoxicity in protection against cytopathic and noncytopathic viruses , 1995, European journal of immunology.

[112]  R. Ueda,et al.  Immune function in mice lacking the perforin gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[113]  R. Dutton,et al.  Role of Effector Cell-Derived IL-4, IL-5, and Perforin in Early and Late Stages of Type 2 CD8 Effector Cell-Mediated Tumor Rejection1 , 2001, The Journal of Immunology.

[114]  J. Trapani,et al.  Initiation of Apoptosis by Granzyme B Requires Direct Cleavage of Bid, but Not Direct Granzyme B–Mediated Caspase Activation , 2000, The Journal of experimental medicine.

[115]  T. Schumacher,et al.  Expression of the Serpin Serine Protease Inhibitor 6 Protects Dendritic Cells from Cytotoxic T Lymphocyte–Induced Apoptosis , 2001, The Journal of experimental medicine.

[116]  R. Welsh,et al.  Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells , 1997, Journal of virology.

[117]  H. Ljunggren,et al.  A Central Role for Death Receptor-Mediated Apoptosis in the Rejection of Tumors by NK Cells1 , 2001, The Journal of Immunology.

[118]  D. Thiele,et al.  Virally Infected Hepatocytes Are Resistant to Perforin-Dependent CTL Effector Mechanisms1 , 2001, The Journal of Immunology.

[119]  J. Harty,et al.  Influence of effector molecules on the CD8(+) T cell response to infection. , 2002, Current opinion in immunology.

[120]  R. Offringa,et al.  Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine , 2001, The Journal of experimental medicine.

[121]  H. Ljunggren,et al.  Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1) , 1996, Immunity.

[122]  J. Trapani,et al.  CTL granules: evolution of vesicles essential for combating virus infections. , 1999, Immunology today.

[123]  R. Langman,et al.  Lack of both Fas Ligand and Perforin Protects from Flavivirus-Mediated Encephalitis in Mice , 2002, Journal of Virology.

[124]  B. Zhong,et al.  Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells , 2000, Nature Immunology.